About the Journal

Gulf Analytics publishes quality peer-reviewed journal (Annals of Gulf Medicines, E-ISSN 2616-9231)

This journal is started with the help of researchers and supervisors of  Kingdom of Saudi Arabia. We publish quality material which includes Original Research papers, Review Articles, Case Reports, Short Communication, View Point, Systematic Review, Correspondence.

We are an highly motivated group of Editors trying to publish latest research to build a better environment for the future generation. We do seven types of review process including two blind peer reviews. We enrich the content and ensure its quality before going for publication.

 

Please Contact us:

Annals of Gulf Medicines. ISSN 2616-9231

Email: analyticsgulf@gmail.com

 

Ethical Standards

Annals of Gulf Medicines maintain the highest standards of peer review while increasing the efficiency of the process.

 

All research articles published in Annals of Gulf Medicines undergo full peer review, key characteristics of which are listed below:

 

All research articles are reviewed by at least two qualified experts.

All publication decisions are made by the journals’ Editors-in-Chief on the basis of the reviews provided

Members of the international Editorial Boards lend insight, advice and guidance to the Editors-in-Chief generally and to assist decision making on specific submissions

Editorial Assistants provide the administrative support that allows Annals of Gulf Medicines journals to maintain the integrity of peer review while delivering rapid turnaround and maximum efficiency to authors, reviewers and editors alike.

Annals of Gulf Medicines additionally benefit through the manuscript referral process from the high quality peer review conducted by established journals.

 

Peer review of referred papers:

Editors of Annals of Gulf Medicines will decide promptly whether to accept, reject, or request revisions of referred papers based on the reviews and editorial insight of the supporting journals. In addition, Editors will have the option of seeking additional reviews when needed. Authors will be advised when Editors decide further review is needed.

 

Peer review of novel submissions:

Articles submitted directly to Annals of Gulf Medicines will be fully peer reviewed by at least two appropriately qualified experts in the field selected by the Editor-in-Chief. The Editor-in-Chief or a designated member of the Editorial Board will then decide whether to accept, reject or request revisions based on the reviews and comments received.

Editors will decide whether each submission reports well-conducted research with conclusions supported by the data presented in the paper.

 

Withdrawal of Manuscripts

Authors are not allowed to withdraw submitted manuscripts, because the withdrawals are waste of valuable resources that editors and referees spent a great deal of time processing submitted manuscript, money and works invested by the publisher.

However, it is unethical to withdraw a submitted manuscript from one journal if accepted by another journal. Withdrawal of manuscripts are only allowed after withdrawal request has been made to the Publisher.

Hazards and Human or Animal Subjects

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.

Fundamental errors in published works

When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

Annals of Gulf Medicines  is the official journal of Gulf Analytics. It is an international peer-reviewed journal. Annals of Gulf Medicines is devoted to research and review articles in the field of Medical, Nursing, Dental, Pharmacy and related discipline of health sciences. The purpose of this journal is to promote excellence in the pharmacy and health sciences and closely related fields. The articles may include new experimental methods of medical importance; new results obtained experimentally; new interpretation of existing results or data pertaining to clinical problems; or epidemiological work giving substantial scientific information pertaining sciences. The current emphasis of the journal includes (but is not limited to) the following areas:

  • Pharmaceutical Sciences (including Pharmaceutics, Pharmacology, Pharmacognosy, Pharmaceutical Chemistry and Pharmacy Practice etc)
  • Medical Sciences (pre-clinical, para-clinical and clinical)
  • Dental Sciences
  • Nursing Health Sciences
  • Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH)
  • Physiotherapy and Rehabilitation Sciences